SCHEMBL5329038

SCHEMBL5329038

C=CCNC1=C(C)C(=O)C(NC(C)=O)=CC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.40
S100A4 P26447 1/20 0.37
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
HTT P42858 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
PIK3CG P48736 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KMT2A Q03164 2/20 0.35
MITF O75030 1/20 0.35
NSD2 O96028 1/20 0.35
LMNA P02545 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5328866 0.80 TDP1 (0.42) TDP1S100A4HPGDKDM4EHSD17B10
SCHEMBL5328420 0.79 TDP1 (0.41) TDP1S100A4ALDH1A1KMT2AMEN1
SCHEMBL5326748 0.79 TDP1 (0.41) TDP1S100A4ALDH1A1KDM4EMAPT
SCHEMBL14233618 0.77 ALDH1A1 (0.41) ALDH1A1HPGDHTTKDM4EMAPT
SCHEMBL14386783 0.69 TDP1 (0.49) TDP1S100A4ALDH1A1HPGDKMT2A
SCHEMBL5330070 0.68 TDP1 (0.47) TDP1S100A4ALDH1A1HPGDKDM4E
SCHEMBL28113788 0.68 TDP1 (0.36) TDP1S100A4ALDH1A1SMN1; SMN2
SCHEMBL7898077 0.65 NSD2 (0.40) TDP1S100A4ALDH1A1HPGDKDM4E
SCHEMBL10883313 0.65 KMT2A (0.49) TDP1ALDH1A1HPGDHTTKDM4E
SCHEMBL11241564 0.64 TDP1 (0.42) TDP1S100A4ALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO claimed
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO disclosed
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO disclosed